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and sophisticated interactions occur among these cells,   primarily 
via soluble protein messengers called cytokines. Important for this 
review, bidirectional communication between the brain and immune 
system by cytokines has signiﬁ  cant consequences for behavior. For 
instance, sick animals exhibit several well- characterized behavioral 
changes, including reductions in food and water intake, activity, 
exploration, and social and sexual interactions (Hart, 1988; Kent 
et al., 1992). Importantly, these so-called “sickness behaviors” are 
not mediated by the infectious pathogens themselves, but rather are 
orchestrated by the host via cytokines (Dantzer and Kelley, 2007). 
Numerous studies have now demonstrated that these behaviors 
are organized, adaptive strategies that are critical to host survival 
(Dantzer and Kelley, 2007; Nesse and Williams, 1994). Thus, sick-
ness behavior reﬂ  ects an overall change in the motivational state 
of the individual that is organized by both the nervous and the 
immune systems.
We believe that cytokines are important not only for behavio-
ral changes during acute illness, but may also underlie long-term 
changes in behavior as a consequence of infection early in life. 
Thus, the purpose of this review is to: (1) summarize the evidence 
that infections occurring during the perinatal period can produce 
effects on brain and subsequent behavior that endure through-
out an organism’s life span, and (2) discuss the potential role of 
cytokines and glia in these long-term changes. Cytokines are pro-
duced within the brain during normal brain development, but are 
expressed at much higher levels during the course of an immune 
INTRODUCTION
Developmental or “fetal programming” is an area of research 
that has received increasing interest in recent years. This ﬁ  eld has 
emerged based on the idea that experience during the perinatal 
period may modulate or “program” the normal course of develop-
ment, with the result that adult outcomes, including behavior, are 
signiﬁ  cantly and often permanently altered (Bennet and Gunn, 
2006). Much of this work has been done in relation to the long-term 
consequences of early-life stress and resulting glucocorticoid expo-
sure, maternal interactions, and fetal growth (Champagne, 2008; 
de Boo and Harding, 2006; Owen et al., 2005, and see this issue). 
In contrast, the role of the immune system in neurodevelopment 
and potential effects on brain and behavior in adulthood remains 
relatively unexplored. Nonetheless, there is strong evidence that 
perinatal exposure to infectious agents has a number of inﬂ  uences 
on later life, including reactivity to stress, disease susceptibility, and 
notably, increased vulnerability to cognitive and/or neuropsychi-
atric disorders, including Alzheimer’s, Parkinson’s, schizophrenia, 
and autism (Hornig et al., 1999; Nelson and Willoughby, 2000; 
Rantakallio et al., 1997; Shi et al., 2003).
Beyond its traditional role in host defense, the immune sys-
tem is now considered a diffuse sensory organ and regulator of 
metabolism, which works in concert with the nervous system to 
achieve and maintain homeostasis throughout the body (Husband, 
1995; Vitkovic et al., 2000). Immunocompetent cells are located 
throughout virtually every organ of the body, including the brain, 
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response. In contrast to overt neural damage, we present data 
indicating that increased cytokine exposure during key periods of 
brain development may also act as a “vulnerability” factor for later-
life pathology, by sensitizing the underlying neural substrates and 
altering the way that the brain responds to a subsequent immune 
challenge in adulthood. In turn, this altered immune response has 
signiﬁ  cant and enduring consequences for behavior, including 
social, cognitive, and affective abilities. We discuss the evidence 
that one mechanism responsible for enduring cytokine changes is 
chronic activation of brain microglia, the primary immunocom-
petent cells of the CNS.
IMMUNE ORIGINS OF NEURODEVELOPMENTAL DISORDERS
A link between infection and neuropsychiatric disorders has a long 
history, beginning as early as the establishment of the germ theory of 
diseases (e.g., “the infectious theory of psychosis”, recently reviewed 
by Yolken and Torrey, 2008), a full discussion of which goes beyond 
the scope of this paper. However, it is worth noting that one of the 
strongest relationships in the literature for a speciﬁ  c developmental 
origin of psychopathology is that between infection and the later 
presentation of schizophrenia (Fruntes and Limosin, 2008; Meyer 
et al., 2005; Yolken and Torrey, 2008). Such a connection may have 
ﬁ  rst been proposed by Scottish psychiatrist Thomas Clouston in 
1891, in which he suggested a developmental component to “adoles-
cent insanity” (Bennet and Gunn, 2006). This literature has recently 
been extensively reviewed (Fatemi and Folsom, 2009). Brieﬂ  y, the 
mechanisms by which infections may lead to psychopathology, 
either alone or in genetically vulnerable individuals, include direct 
infection of the developing fetus and subsequent abnormal neural 
development, the generation of auto-antibodies by the mother that 
subsequently react with fetal neural tissue, and, notably, cytokine 
production, which may be involved in all of these mechanisms 
(Pearce, 2001). There are several reports in humans that inﬂ  uenza 
infection induces cytokine production by the maternal immune 
system, the fetal immune system, and the placenta (Hillier et al., 
1993; Urakubo et al., 2001), and each has been linked to increased 
risk of schizophrenia in the offspring (Brown et al., 2004). Similarly, 
inﬂ  uenza administered to pregnant mice increases cytokine levels in 
placental tissue and amniotic ﬂ  uid, and results in abnormal develop-
ment of the offspring (Shi et al., 2003). Notably, a replicating virus 
is not required; rats exposed prenatally to double-stranded RNA, a 
viral mimic and synthetic cytokine inducer, exhibit hippocampal 
dysmorphology and an impaired ability to ﬁ  lter irrelevant informa-
tion, traits characteristic of schizophrenia in humans (Zuckerman 
and Weiner, 2003). It should be noted that there remains consid-
erable debate about this topic, as the majority of individuals that 
suffer from infections early in life do not develop schizophrenia 
(Bennet and Gunn, 2006). Nonetheless, it is clear that a link is present 
in at least a subset of individuals, and these combined data from 
the schizophrenia literature have in large part set the stage for an 
“immune origins of neurodevelopmental disorders hypothesis” 
(Meyer et al., 2005), which extends more broadly to a number of 
cognitive and affective disorders.
NORMAL BRAIN DEVELOPMENT
Researchers continue to identify ways in which the immune 
system inﬂ   uences normal brain development (Merrill, 1992). 
Developmental and region speciﬁ  c regulation of cytokine expression 
has been demonstrated (Pousset, 1994), suggesting an important 
role for individual cytokines in the development of speciﬁ  c brain 
regions. IL-1β is expressed at high levels in the developing CNS, but 
at very low (constitutive) levels in the adult brain (Giulian et al., 
1988; Schmitz and Chew, 2008). Cytokines are critically involved in 
neuronal and glial cell migration, differentiation, synaptic matura-
tion, and many other important processes of brain development 
(Nawa and Takei, 2006). Glial cells also play crucial roles in a wide 
variety of developmental processes, including apoptosis, axonal 
growth, and angiogenesis (Rakic and Zecevic, 2000; Streit, 2001). 
Astrocytes are critical for the formation of synapses during devel-
opment (Ullian et al., 2004), and microglial development occurs 
in parallel with neurogenesis in most brain structures (Rice and 
Barone, 2000). Finally, we know that proteins of the classical com-
plement cascade, important for innate immunity and pathogen 
elimination in the periphery, are also required for developmental 
synapse elimination within the CNS (Stevens et al., 2007).
CYTOKINES AND INFECTION
Given their crucial role in brain development, it is not surprising 
that elevated levels of pro-inﬂ  ammatory cytokines generated by 
the maternal or fetal immune system during perinatal infection 
have been associated with abnormal fetal brain development and 
increased risk for neurodevelopmental disorders (Cai et al., 2000; 
Meyer et al., 2006; Pang et al., 2003; Richardson-Burns and Tyler, 
2004; Urakubo et al., 2001; Yu et al., 2004). For instance, concentra-
tions of IL-1β, IL-6, and tumour necrosis factor (TNF) are elevated 
in infants with severe perinatal complications (Miller et al., 1990), 
and children with bacterial meningitis have elevated levels of IL-1β 
that strongly correlate with the occurrence of neurological disorders 
(Mustafa et al., 1989). Increased levels of IL-6 in amniotic ﬂ  uid have 
also been a clinically useful marker of increased risk for neurologi-
cal disorders and morbidity (Yoon et al., 1995). Lipopolysaccharide 
(LPS), the cell wall component of gram-negative bacteria, has been 
used to mimic infection in many studies because it initiates a rapid 
and well-characterized immune response (see Wang et al., 2006 for 
review). LPS markedly induces cytokine expression in the immature 
rat brain, which has been linked to white matter injury and cerebral 
palsy (Cai et al., 2000; Fidel et al., 1994; Golan et al., 2005; Urakubo 
et al., 2001). LPS also induces a number of long-term behavioral 
changes, which we discuss more fully below. Importantly, in each 
of these cases the infectious agents themselves do not enter the 
fetal circulation, thus implicating the critical role of the maternal 
immune response. Furthermore, the strong association between 
infection and developmental disorders spans a diverse number of 
bacterial and viral agents, suggesting a common mechanism such 
as cytokine release.
EARLY-LIFE INFECTION AND COGNITIVE IMPAIRMENT
Bacterial infections represent the number one cause of infection in 
newborns worldwide, and are a signiﬁ  cant cause and consequence 
of premature birth, which have increased 30% in the past 25 years 
(Osrin et al., 2004; Skogstrand et al., 2008). Human newborns 
are particularly impaired in their abilities to mount an immune 
response against the polysaccharide regions of bacteria, which 
results in signiﬁ  cant infant mortality, particularly in   developing Frontiers in Behavioral Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 14  |  3
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countries (Marshall-Clarke et al., 2000; Osrin et al., 2004). Major 
recent advances in maternal and perinatal medicine have greatly 
increased survival rates among these populations in developed coun-
tries. However, it remains to be determined what the total impact 
of infection during the perinatal period may have on subsequent 
physiology and behavior in individuals (see Adams-Chapman and 
Stoll, 2006; Hagberg and Mallard, 2005 for review). We have devel-
oped a model of postnatal bacterial infection in order to explore 
these questions. Rats are injected subcutaneously on postnatal day 
(P) 4 with phosphate-buffered-saline (PBS) or a non-lethal dose of 
live Escherichia coli. P4 was originally selected based on models of 
neonatal LPS challenge in rats (Hodgson et al., 2001; Shanks et al., 
2000), and represents a time relatively comparable to the third 
trimester in humans, during which signiﬁ  cant brain growth occurs 
(Dobbing and Sands, 1979; Rodier, 1980). Thus, the newborn rat 
is arguably a good model for human premature infants (Vaccarino 
and Ment, 2004). E. coli is the number one cause of infection in 
low-birth weight premature infants in the US (Stoll et al., 2005), 
which is largely resistant to antibiotics (Stoll et al., 2005).
Our data have demonstrated that neonatal E. coli infection in 
pups markedly increases circulating cytokines (IL-1β, IL-6, TNF) 
and the primary stress hormone, corticosterone, for at least 48 h 
after infection (Bilbo et al., 2005a). Within the brain, there is a 
signiﬁ  cant and speciﬁ  c increase in IL-1β mRNA and protein (Bilbo 
et al., 2005a), but not in other analyzed cytokines (IL-6, TNF), 
compared to PBS injection. These results suggest that IL-1β may 
be a key mediator of events occurring within the developing brain 
in response to infection at this time. These data are intriguing given 
evidence that IL-1β levels are naturally elevated in the neonatal 
brain, peaking around P2, and declining thereafter into adulthood 
(Giulian et al., 1988). Thus, neonatal infection leads to exagger-
ated IL-1β production at a time that a natural developmental peak 
occurs, suggesting that this may be a sensitive period for inﬂ  uences 
on this particular cytokine. Further support for this idea is evidence 
that human placenta from full-term infants increases the release 
of IL-1β receptor antagonist compared to IL-1β in response to 
LPS, whereas preterm infant placenta increases both equally (and is 
thus more inﬂ  ammatory), suggesting the early fetal period is quite 
distinct from later developmental time points in terms of cytokine 
expression (Holcberg et al., 2008).
COGNITIVE IMPAIRMENT
What enduring effects does such exposure have on the brain, and 
ultimately on behavior? Sepsis in infants was ﬁ  rst linked to white 
matter damage in the 1970s (Leviton and Gilles, 1973), and there is 
now a strong literature linking perinatal infection to cerebral palsy 
(see Garnier et al., 2003; Huleihel et al., 2004 for review). Beyond 
these major developmental impairments, one of the most com-
mon consequences of perinatal infection/inﬂ  ammation generally 
is cognitive dysfunction, including learning, memory, and attention 
disorders (Bauman et al., 1997). E. coli infections in particular in 
premature infants are associated with signiﬁ  cant neurodevelop-
mental delays, which occur regardless of infection location (e.g., 
brain, blood, or intestines; Stoll et al., 2004). Pro-inﬂ  ammatory 
cytokines in the amniotic ﬂ  uid and/or neonatal blood stream 
are cited as the primary predictor of adverse outcomes (Deguchi 
et al., 1996; Leviton and Dammann, 2002). Cytokine receptors 
are   distributed throughout the brain, but have one of the highest 
densities in the hippocampus (Cunningham and De Souza, 1993; 
Schneider et al., 1998). The hippocampus also exhibits marked vul-
nerability (compared to other brain regions) to events such as severe 
stress, epilepsy, stroke, and cardiac arrest (Fujioka et al., 2000; Petito 
et al., 1987; Salmenpera et al., 1998; Sapolsky et al., 1990). Thus the 
hippocampus, and thus cognition, may be particularly vulnerable 
to immune-related alterations (Lynch et al., 2004; Morrison and 
Hof, 1997).
One implication of the previous discussion is that early-life infec-
tion might inﬂ  uence the formation of memories that depend on the 
hippocampus in adulthood. Initially, we considered two possible 
ways by which neonatal infection may inﬂ  uence memory: (1) it 
could directly inﬂ  uence the neural pathways supporting memory 
or, (2) it could alter how the adult animal responds to a subsequent 
immune challenge, thereby affecting the processes that support 
memory. Our initial experiments centered on a modiﬁ  ed version 
of contextual fear conditioning known as the context pre-exposure 
task (Fanselow, 1990; Rudy et al., 2004). This paradigm assesses the 
rat’s memory for a recently explored context. In this task, when a rat 
is placed into a conditioning context and immediately shocked, he 
later displays little or no conditioned fear (freezing) to the context. 
This absence of fear to the context is thought to occur because an 
immediately shocked rat does not have the opportunity to sample 
the environment and thus store a representation of its features. 
However, if a rat is pre-exposed to the context for several minutes 
the day before, immediate shock conditioning will then produce 
substantial freezing on a subsequent test day (Fanselow, 1990; Rudy 
and O’Reilly, 2001; Westbrook et al., 1994). Importantly, each stage 
of this task is critically dependent on the hippocampus (Rudy and 
O’Reilly, 2001; Rudy et al., 2002, 2004).
In order to discriminate between the two possible ways an 
early-life infection might inﬂ  uence memory, we designed our 
experiments so that we could determine whether the E. coli infec-
tion itself affected memory permanently throughout the remain-
der of the lifespan, or if it affected instead the adult’s immune 
response to a subsequent infectious challenge, which might then 
affect memory. In the latter case, the memory impairment would 
only be “unmasked” by a subsequent immune challenge. Rats 
were treated on P4 with PBS or E. coli as described previously, 
and were then as adults pre-exposed to a novel environment on 
the ﬁ  rst day of testing. Immediately after pre-exposure, rats from 
each neonatal group received no injection, saline, or a low-dose 
immune challenge (25 µg/kg intraperitoneal bacterial LPS). Thus, 
if infection on P4 altered the neural pathways that support mem-
ory formation, then these rats should display impaired memory 
regardless of whether they received the LPS immune challenge 
after pre-exposure. However, if the infection on P4 altered how 
the adult immune system responds to the second challenge, then 
only rats that experience the combination of the infection on P4 
and LPS after training should display impaired memory. As shown 
in Figure 1A, rats that experienced the combination displayed 
impaired memory for the explored context. In contrast, rats that 
only experienced the P4 infection were not affected, identical to 
PBS controls in any condition. These data support option 2 above, 
i.e., that some aspect of the immune reaction is itself interfering 
with memory.Frontiers in Behavioral Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 14  |  4
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FIGURE 1 | Early-life infection alters memory, cytokine expression, and 
microglial activation after a subsequent immune challenge in adulthood. 
(A) Mean (+SEM) percent freezing during the context pre-exposure task. Neonatal 
E. coli infection impairs memory formation in adulthood only in the presence of a 
subsequent immune challenge, LPS (white bars; *p < 0.05 from all other groups) 
(adapted from Bilbo et al., 2005a). (B) Mean (+SEM) relative gene expression 
of IL -1β and BDNF in the hippocampus during the context pre-exposure task. 
Neonatal E. coli infection induces a more than three-fold increase in the 
transcription of IL -1β only when exposed in adulthood to LPS (white bars). Animals 
infected neonatally with E. coli also show the greatest decrease in hippocampal 
BDNF levels 4 h after context pre-exposure and subsequent LPS (*p < 0.05 
compared to Vehicle treated animals from same neonatal treatment group; 
#p < 0.05 compared to Control) (adapted from Bilbo et al., 2008a). (C) Mean 
(+4 SEM) relative gene expression of MHC II in the hippocampus, a marker of 
microglial activation. MHC II activity in response to a vehicle injection (black bars) 
is low in both groups. Neonatal E. coli infection combined with adult LPS (white 
bars) signiﬁ  cantly increases microglial activation above all other treatment groups 
(*p < 0.05). These data are consistent with the idea of glial priming, illustrated by 
the cartoon pictorials, in that neonatal infection can permanently activate or 
“prime” microglia leading to an exaggerated response to LPS.Frontiers in Behavioral Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 14  |  5
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Additional behavioral experiments have revealed the selective 
nature of the impairment. The combination of P4 infection and 
adult LPS impaired the long-term (48 h) but not the short-term 
(1 h) memory for a contextual fear experience, indicating that the 
rats initially learned the association, but that long-term consolida-
tion was impaired or prevented. Moreover, this treatment had no 
effect on conditioned fear to a tone paired with shock. This ﬁ  nding 
is important because conditioning to a tone does not depend on the 
hippocampus (Bilbo et al., 2006). Collectively these results support 
the hypothesis that the P4 infection leads to selective impairment 
of a long-term memory that depends on the hippocampus.
Three additional points should also be mentioned: First (and 
most critical), an infection later in development, on P30, does not 
lead to LPS-induced memory impairment later in life (Bilbo et al., 
2006). These data indicate that the early-infection induced vulner-
ability is speciﬁ  cally a developmental effect, and not a general sen-
sitizing event that can occur at any time. Second, no differences in 
overall activity, basal anxiety, or exploration have been observed in 
adulthood as a consequence of the neonatal infection (Bilbo et al., 
2006). Third, we have also observed no differences in spatial learn-
ing or memory using a water maze task performed in the absence 
of an adult LPS injection (Bilbo et al., 2007). This is consistent with 
our ﬁ  ndings that neonatal infection by itself has no overt effects on 
hippocampal memory formation in adulthood. However, we did 
ﬁ  nd that P4 E. coli infection prevents a beneﬁ  cial/augmenting effect 
of neonatal handling (brief, daily separation of pups from mom) 
on both anxiety and spatial memory in adulthood, a paradigm 
that consistently enhances learning and memory and decreases 
anxiety (Caldji et al., 1998; Fish et al., 2004; Liu et al., 2000). In 
summary, the collective results yield two important conclusions. 
First they support the hypothesis that the infection occurring dur-
ing a sensitive period of life leads to a selective impairment in the 
consolidation of memories that depend on the hippocampus in 
adulthood. Second, the early infection produces a latent or hidden 
change in the immune system that is unmasked by either a second 
immune challenge or by preventing the effectiveness of the han-
dling intervention. These data are well in accord with much of the 
human schizophrenia literature, which posits that a combination 
of early perinatal plus young-adult challenge (e.g., stress, infection) 
is required for the manifestation of the illness, the so-called “two-
hit hypothesis” (Choy et al., 2009; Keshavan, 1999; Maynard et al., 
2001; Pantelis et al., 2003).
WHAT IS THE ROLE OF CYTOKINES IN MEMORY?
A growing body of evidence suggests a role for cytokines, notably 
IL-1β, in normal, non-pathological, synaptic plasticity mechanisms 
within the brain, including memory (McAfoose and Baune, 2009). 
IL-1β is induced within the hippocampus in response to fear condi-
tioning (Goshen et al., 2007), and is critical for long-term potentia-
tion (LTP) maintenance during learning (Ross et al., 2003; Spulber 
et al., 2009). Mice lacking endogenous IL-1β or its receptor, or with 
overexpression of the endogenous IL-1 receptor antagonist (IL-
1ra), exhibit markedly impaired hippocampal-dependent learning 
and memory (Goshen et al., 2007; Spulber et al., 2009).
In contrast to these data, exaggerated IL-1β within the brain is 
also strongly associated with memory impairment. IL-1β is the most 
consistently induced cytokine within the brain  following immune 
stimulation (Abraham and Williams, 2003), but is very tightly 
 regulated in the normal brain, suggesting that any dysregulation will 
result in pathology. Patients with AIDS-related dementia, cancer, 
chronic inﬂ  ammatory diseases (e.g., Alzheimer’s), or autoimmune 
diseases often exhibit exaggerated levels of IL-1β co-occurring with 
cognitive impairment (Gallo et al., 1989; Grifﬁ  n et al., 1989; Meyers, 
2000; Stanley et al., 1994). Exogenously applied IL-1β inhibits LTP 
in vitro within major hippocampal pathways (Cunningham et al., 
1996; Katsuki et al., 1990). Similarly, peripheral high dose LPS inter-
feres with LTP in vivo, with this effect depending on hippocampal 
IL-1β production (Vereker et al., 2000). Finally, rats injected with 
high levels of IL-1β directly into the dorsal hippocampus display 
memory impairments (Barrientos et al., 2002; Pugh et al., 1999), 
as do rats that receive other treatments that induce hippocampal 
IL-1β (Pugh et al., 1998).
Based on these data, we explored whether IL-1β production 
in the hippocampus is dysregulated in response to the LPS chal-
lenge in adulthood as a consequence of the early-life infection. 
We ﬁ nd no detectable IL-1β protein within the hippocampus of 
either group following a saline injection, indicating that neonatal 
infection does not result in a chronic exaggerated IL-1β response 
within the brain. However, in response to LPS, early-infected rats 
exhibit a prolonged expression of IL-1β protein speciﬁ  cally within 
the hippocampus and adjacent association cortex (Figure 1B). At 
the messenger RNA level, the genes encoding for IL-1β, IL-1β con-
verting enzyme (caspase-1), and the IL-1β type I receptor, are all 
signiﬁ  cantly elevated after LPS within the hippocampus of early-
infected rats compared to controls. Notably, however, mRNA for 
the anti-inﬂ  ammatory IL-1ra is not signiﬁ  cantly elevated above 
controls (Bilbo et al., 2007). Importantly, neither splenic/circulating 
cytokines nor corticosterone production to the adult LPS challenge 
are altered by the neonatal infection, suggesting that these cytokine 
alterations occurring within the brain are not simply a consequence 
of an altered cytokine signal to the brain from the periphery (Bilbo 
et al., 2005a). Thus, the early-life infection appears to create a shift 
towards a pro-inﬂ  ammatory bias in the adult brain. The impor-
tance of these ﬁ  ndings to the memory impairment is conﬁ  rmed by 
preventing the synthesis of IL-1β prior to the LPS in conjunction 
with learning, which completely prevents the memory impairment 
(Bilbo et al., 2005a).
How might exaggerated brain IL-1β expression interfere with 
memory? IL-1β injected directly into the hippocampus dramatically 
suppresses the induction of BDNF following contextual learning, 
a molecule critical for long-term memory formation (Barrientos 
et al., 2004). IL-1β also interferes with the neuroprotective actions 
of BDNF when applied to neuronal cultures (Tong et al., 2008). We 
have reported that prior to conditioning, basal BDNF mRNA does 
not differ in adults as a consequence of early infection. However, 
following fear conditioning, adult LPS decreases BDNF mRNA 
induction in all hippocampal regions of neonatally-infected rats 
compared to controls, and induces a faster decay within CA1. This 
decrease in E. coli rats is accompanied by a large increase in IL-1β 
mRNA in CA1 (Bilbo et al., 2008a).
Taken together, our results suggest that excess IL-1β at the time 
of learning can set in motion a cascade, involving BDNF and likely 
other cellular players, that ultimately impairs memory. Importantly, 
PBS controls did also increase IL-1β protein in response to the Frontiers in Behavioral Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 14  |  6
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low-dose LPS, but this increase did not impair memory. Collectively, 
these data provide support for an inverted “U” function for IL-1β 
and memory, with physiological levels being important for mem-
ory, and any deviation from this range resulting in pathology and 
impairment (Goshen et al., 2007; Spulber et al., 2009). Early-life 
infection appears to sensitize the “cytokine thermostat”, so to speak, 
with profound implications for optimal production within the 
brain and ultimately, cognitive function.
MECHANISMS UNDERLYING ENDURING CONSEQUENCES OF 
EARLY-LIFE INFECTION
Our results suggest that a neonatal infection can alter the devel-
opmental trajectory of the immune system and the brain. They 
support the idea that whereas direct neurological injury is often 
associated with severe neonatal infection (e.g., Borna Disease Virus 
or high dose LPS), mild-to-moderate infection and subsequent 
cytokine exposure during key periods of brain development may 
result in more subtle alterations, such as altering the response or 
vulnerability to a subsequent insult (Hagberg and Mallard, 2005). 
For instance, low-dose LPS administration in the immature brain 
several days prior to hypoxia/ischemia results in far more damage 
than ischemia alone (i.e., sensitization) (Cai et al., 2000; Eklind 
et al.,  2001). In contrast, pretreatment with pro-inﬂ  ammatory 
cytokines has also been shown to protect against subsequent cer-
ebral ischemia or cytotoxic insult, a phenomenon known as precon-
ditioning (Hagberg et al., 2004). Whether an inﬂ  ammatory event 
within the CNS confers either resilience or vulnerability to a later 
challenge is a key unanswered question. In the next sections we 
review some of the potential pathways whereby neonatal infec-
tion might exert its inﬂ  uence on long-term changes in IL-1β, and 
subsequent behavioral changes.
CYTOKINES AND GLIA
One of the most consistent changes associated with perinatal infec-
tion is glial activation (Billiards et al., 2006). Interestingly, one of 
the ﬁ  rst physicians to suggest a relationship between infection and 
later psychosis in the late 19th century cited “changes in glia” as one 
4 primary anatomical changes within the brain (Kraepelin, 1919). 
While virtually ignored for years by the neuroscience community, 
the literature on glia has now reached a critical mass; to name but 
two recent reviews, glia are described as critical for “every major 
aspect of brain development, function, and disease” (Barres, 2008), as 
“central in brain homeostasis”, and that, “brain pathology is, to a very 
great extent, a pathology of glia” (Giaume et al., 2007). Microglia 
are the primary immunocompetent cells of the brain, existing 
under non-pathological conditions in a resting, highly ramiﬁ  ed 
morphology, with low or non-detectable expressions of cell surface 
“activation” markers (e.g., CD11b [complement 3 receptor/CR3], 
major histocompatibility complex [MHC] II). However, the term 
“activation” marker is somewhat of a misnomer, given that resting 
cells are by no means dormant or inactive. Nonetheless, in response 
to injury or immune stimulation, microglia become considerably 
more active, and upregulate a number of the aforementioned sur-
face receptors (Morale et al., 2006). Once activated, glia produce a 
plethora of cytokines, chemokines [e.g., monocyte chemoattractant 
protein (MCP)-1], and other inducible factors [e.g., nitric oxide 
(NO), superoxide], which in turn inﬂ  uence neural function.
GLIA AND EARLY BRAIN DEVELOPMENT
Most researchers believe that microglia derive from mesodermal 
precursors such as inﬁ  ltrating blood monocytes during pre- and 
postnatal life, beginning around embryonic day 14 in rodents (Ling 
and Wong, 1993). Notably, the ﬁ  rst week of life in rats is a time of 
extensive brain growth when microglial proliferation, migration, 
and density peak (Bayer et al., 1993; Wu et al., 1992). Furthermore, 
a number of studies have demonstrated that microglia are largely in 
an activated or amoeboid state during the early postnatal period, in 
contrast to the quiescent, ramiﬁ  ed microglia found in adults (Fujita 
et al., 1981; Ling and Wong, 1993; Rezaie et al., 1997). Interestingly, 
the developmental peak in IL-1β concentrations discussed earlier 
coincides exactly with the presence of ameboid microglia in the 
rat brain (Giulian et al., 1988). For these reasons, we have hypoth-
esized that the early postnatal stage may be particularly vulner-
able to insult, with subsequent changes in microglial cell number, 
function, and/or neural trajectory (i.e. vulnerability or protection) 
(see Figure 2). Microglia are an excellent candidate for long-term 
changes within the brain, because these cells are long-lived and can 
become and remain chronically activated (Town et al., 2005).
To test this hypothesis, we assessed the impact of early-life infec-
tion on glial activation by measuring expression levels for CD11b 
mRNA in neonate brains immediately following E. coli infection. 
We found a signiﬁ  cant, sustained increase (≥72 h) in the same hip-
pocampal tissue in which we observed increased IL-1β (Bilbo et al., 
2005a). Moreover, both CD11b and IL-1β expression increased with 
the same time course, peaking 24 h post-infection. Although this 
remains to be demonstrated directly, these ﬁ  ndings suggest that the 
source of the IL-1β in the neonate brains in response to neonatal 
infection is activated microglia. In contrast, expression levels of the 
astrocyte cell marker glial-ﬁ  brillary acidic protein (GFAP) did not 
change, suggesting a selective change in microglial activation after 
neonatal infection (Bilbo et al., 2005a).
DOUBLE-EDGED SWORD OF MICROGLIA
The long-term consequences of early infection-induced changes 
in microglial cell number or function in adulthood are largely 
unknown. Microglia have demonstrated roles in both protection 
and pathology. For instance, they produce neurotrophic factors that 
aid in cellular repair, and recruit immune cells into the brain, which 
aid in clearing infection or cellular debris (Lalancette-Hebert et al., 
2007). Furthermore, the selective ablation of microglia following 
stroke worsens outcome (Lalancette-Hebert et al., 2007). In con-
trast to these beneﬁ  ts, chronic or exaggerated microglial activation 
is associated with multiple neuroinﬂ  ammatory and neurodegen-
erative diseases, including Parkinson’s disease, Multiple Sclerosis, 
Alzheimer’s, and Huntington’s disease (Perry, 2004).
GLIAL PRIMING
The factors that may cause a switch in glial function from helpful 
to harmful remain speculative. However, there is increasing sup-
port for the concept of “glial priming”, in which cells can become 
sensitized by an insult, challenge, or injury, such that subsequent 
responses to a challenge are exaggerated (Perry et al., 2003). For 
instance, a systemic inﬂ  ammatory challenge in an animal with 
a chronic neurodegenerative disease leads to exaggerated brain 
inﬂ  ammation compared to a control animal (Combrinck et al., Frontiers in Behavioral Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 14  |  7
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2002). The morphology of primed glial cells is similar to that of 
“activated” cells (e.g. amoeboid, phagocytic), but primed glial cells 
do not chronically produce cytokines and other pro-inﬂ  ammatory 
mediators typical of cells in an activated state. Upon challenge, 
however, such as infection or injury in the periphery, these primed 
cells will over-produce cytokines within the brain compared to 
cells that were not previously primed or sensitized (Perry et al., 
2002). This overproduction may then lead to cognitive and/or 
other impairments (Cunningham et al., 2005; Frank et al., 2006; 
Godbout et al., 2005).
We know that an E. coli infection activates hippocampal micro-
glia in neonatal pups. The ﬁ  nding that glia can be primed long-term 
raises the critical question, does early-life infection prime glia into 
adulthood? To answer this question we quantiﬁ  ed mRNA levels for 
two different cell surface activation markers (CD11b and MHC II) 
in the adult hippocampus of rats treated on P4 with PBS or E. coli, 
and injected as adults with saline or LPS. CD11b is both constitu-
tively expressed by microglia and somewhat activity-dependent, 
whereas MHC II is largely expressed only upon activation (Butovsky 
et al., 2005). In E. coli-infected rats, we found that CD11b, but not 
MHC II expression, was elevated following saline compared to 
controls. Furthermore, both markers were signiﬁ  cantly elevated in 
response to adult LPS treatment in E. coli treated rats compared to 
controls (Figure 1C). GFAP was also measured, but again did not 
differ by neonatal or adult treatment (Bilbo et al., 2005a, 2007). 
The increase in CD11b in early-infected rats regardless of adult 
treatment suggests an increase in the number of microglial cells 
(because its expression is relatively constitutive), whereas exagger-
ated MHC II expression (which is activity-dependent) to the LPS 
suggests these cells are sensitized or primed in E. coli rats. Finally, we 
have recent data indicating that the number of cells in adulthood 
is largely unchanged, whereas their morphology is consistent with 
a primed phenotype (Bland et al., submitted).
Is there a sensitive period? Does an immune challenge early in 
life inﬂ  uence brain and behavior in a way that depends on devel-
opmental processes? Since 2000 alone, there have been numerous 
reports in the animal literature of perinatal immune challenges 
ranging from early gestation to the juvenile period, and their con-
sequences for adult offspring phenotypes (see Table 1). It is clear 
that the timing of a challenge is likely a critical factor for later 
outcomes, impacting the distinct developmental time courses of 
different brain regions and their underlying mechanisms (e.g., 
FIGURE 2 | Early brain development is a sensitive period for long-term 
changes in glial cell function. Bone marrow-derived mononuclear cells inﬁ  ltrate 
the brain in rodents beginning around embryonic day (E) 14, where they 
eventually differentiate into fully mature, ramiﬁ  ed microglia by ∼P14. Microglia are 
critical for early brain development, and exist primarily in an amoeboid/phagocytic 
state during this time, and can respond vigorously to infection or injury 
(e.g., cytokine production). In adulthood as well, quiescent microglial can rapidly 
transition into an activated state in response to infection or injury. We hypothesize 
that a subset of glia are permanently maintained in an activated or primed state 
(represented by the dashed line) into adulthood as a consequence of neonatal 
infection. Thus, when animals are exposed to a subsequent immune challenge in 
adulthood, primed microglia produce exaggerated levels of cytokines, which in 
turn impair memory. Early-life priming of microglial function likely has life-long 
consequences for brain function, homeostasis, and ultimately behavior.Frontiers in Behavioral Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 14  |  8
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one   primary reason the early   postnatal period in rats is a sensitive 
or critical period for later-life   vulnerabilities to immune stimuli, 
is because the glia themselves are functionally different at this time. 
Several studies have demonstrated that amoeboid, “macrophage-
like”, microglia ﬁ  rst appear in the rat brain no earlier than E14, 
and steadily increase in density until about P7. By P15 they have 
largely transitioned to a ramiﬁ  ed, adult morphology. Thus, the 
peak in density and amoeboid morphology (and function) occurs 
within the ﬁ  rst postnatal week, with slight variability depending on 
brain region (Giulian et al., 1988; Wu et al., 1992). In the human 
 neurotransmitter system development, synapse formation, glial and 
neural cell genesis, etc; Herlenius and Lagercrantz, 2004; Stead et al., 
2006). However, the original question of whether these changes 
depend on development has been surprisingly little addressed. 
We have demonstrated that infection on P30 does not result in 
memory impairments later in life (Bilbo et al., 2006), nor does 
it induce the long-term changes in glial activation and cytokine 
expression observed with a P4 infection (Bilbo et al., unpublished 
data). The factors deﬁ  ning this “sensitive period” are undoubtedly 
many, as suggested above. However, our working hypothesis is that 
Table 1 | Impact of perinatal immune challenge on adult* offspring behavioral and biochemical outcomes.
Species  Challenge  Time  Adolescent or adult phenotype of offspring  Reference(s)
Mouse  LPS  E8  Impaired object recognition memory  Coyle et al., 2009
Mouse  Poly IC  E9  Impaired pre-pulse inhibition (PPI), latent   Meyer and Feldon, 2008;  
     inhibition and spatial memory; altered GABAA  Meyer et al., 2005; Nyffeler et al., 2006
      receptor subunit expression; reduced prefrontal
     D1  receptors
Mouse  Inﬂ  uenza or   E9.5  Impaired PPI, latent inhibition and social behavior;   Shi et al., 2003, 2009; Smith et al., 2007
  Poly IC   altered cerebellar Purkinje cell development
Rat  Poly IC  E15  Impaired PPI; impaired latent inhibition;   Wolff and Bilkey, 2008; Zuckerman and
     altered hippocampal morphology  Weiner, 2005; Zuckerman et al., 2003
Rat  LPS  E15–16  Decreased dentate gyrus neurogenesis at P14;   Cui et al., 2009; Fortier et al., 2007; 
     altered hippocampal synaptic transmission at  Lowe et al., 2008
      P20–25; decreased PPI
Rat  LPS  E15–19  Decreased nucleus accumbens dopamine   Bakos et al., 2004
     and altered open ﬁ  eld activity
Mouse  Poly IC  E17  Potentiated locomotor activity and altered   Meyer et al., 2008
     NMDA receptor subunit expression
Rat  LPS  E17  Altered hippocampal morphology, decreased   Golan et al., 2005
     learning and memory
Mouse  LPS  E17  Increased anxiety and altered social activity  Hava et al., 2006
Rat  LPS  E18–19  Enhanced amphetamine-induced locomotion   Fortier et al., 2004
     and acoustic startle
Rat  LPS  E1–21  Impaired PPI, increased serum cytokines, and   Romero et al., 2007
     increased nucleus accumbens dopamine
Rat  Borna   P0  Locomotor hyperactivity, and hippocampal and   Hornig et al., 2001 (review)
  Disease    cerebellar damage; spatial learning and memory
 Virus    deﬁ  cits; increased brain cytokines, decreased
      neurotropic factor expression, increased glial
      activation, and cerebral atrophy with stereotypy
Rat  LPS  P3 and P5  Increased HPA response to stress and exaggerated   Shanks et al., 2000; Tenk et al., 2007; 
     startle; decreased stress-induced antibody production;   Walker et al., 2006, 2008, 2009a,b
      blunted corticosterone and increased stress-induced
      anxiety; increased corticosterone and decreased
      adjuvant-induced arthritis; decreased LPS fever; enhanced
      behavioral sensitization to dopamine agonist (quinpirole)
Mouse  LPS  P4–5  Impaired active avoidance, decreased LPS-induced   Kohman et al., 2008
     central IL -1beta mRNA
Rat  LPS  P14  Decreased hypothalamic COX-2 and LPS fever; altered   Boisse et al., 2005; Ellestad et al., 2009; 
     NMDA receptor subunit expression; increased seizure  Galic et al., 2008; Harre et al., 2008
      susceptibility; reduced EAE severity and altered T cell
     subtype  expression
*Unless otherwise noted.
E, embryonic day; P , postnatal day.Frontiers in Behavioral Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 14  |  9
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brain, this same   transition occurs, with a shifted time course of 
late second-to-early third trimester, consistent with comparable 
neural development to the early postnatal rodent (Rezaie and Male, 
2002). Thus, infectious or traumatic events occurring at this time 
are hypothesized to have an increased capacity to inﬂ  uence later-
life neural function via speciﬁ  c, long-term inﬂ  uences on these 
long-living and dynamic cells. By extension, we would predict that 
challenges occurring earlier or later in development would have a 
reduced impact on glia, and thus on long-term glial function.
GENERAL DISCUSSION AND IMPLICATIONS
In this review, we have presented evidence that early-life infection 
with bacteria leads to marked behavioral changes in adulthood. 
The primary change we have characterized is memory impairment 
speciﬁ  c to the hippocampus, which is dependent upon the infec-
tion occurring early in postnatal life, and is only revealed upon 
subsequent immune challenge. We have further determined that 
exaggerated IL-1β production and long-term changes in microglial 
function/activation are associated with this vulnerability. Several 
groups have characterized deﬁ  cits in various aspects of cognition 
in adulthood following early immune challenge, including pre-
pulse inhibition (PPI), latent inhibition, object recognition, and 
active avoidance (see Table 1). Unlike our own work, the major-
ity of these deﬁ  cits occur independent of any adult challenge or 
precipitating event, although not always (e.g., Walker et al., 2008). 
However, several are manifest only in adulthood (e.g., Zuckerman 
and Weiner, 2003), suggesting an underlying developmental mecha-
nism is required to unveil the deﬁ  cits, and together with our own 
work lend support for the “two hit” hypothesis of developmental 
pathology. A number of other behavioral changes are also associ-
ated with early-life immune activity. It goes beyond the scope of 
this paper to thoroughly review this literature, but we highlight 
some of the ﬁ  ndings here for comparison to our own work, and 
their subsequent implications.
HPA AXIS REACTIVITY
The stress axis and the immune system are inextricably linked; 
during infection, cytokines profoundly activate the HPA axis, 
and alterations in HPA axis development and function have been 
  characterized by a number of groups following perinatal immune 
challenge or infection. Unfortunately, this literature is by no means 
clear, beyond the simple consensus that there are changes. For 
instance, neonatal LPS challenge (on P3 and again on P5) increases 
corticosterone within 4 h after exposure (Shanks and Meaney, 
1994), and results in increased anxiety-like behavior in adulthood 
(Breivik et al., 2002; Walker et al., 2004). In contrast, Spencer et al. 
(2006) report no signiﬁ  cant change in adult anxiety following LPS 
on P7, similar to our own ﬁ  ndings with early E. coli. LPS treatment 
on P3/P5 also increases corticosterone responses to stress in adult-
hood (Hodgson et al., 2001; Shanks et al., 2000), although this is not 
always the case (Breivik et al., 2002; Granger et al., 1996). Similarly, 
we have never observed differences in corticosterone in response 
to adult LPS as a consequence of early infection, although we have 
observed differences in corticosterone levels in response to an adult 
(non-immune) stressor, which we discuss more fully below (Bilbo 
et al., 2005a,b, 2008b). Finally, in humans, early childhood infec-
tions are inversely correlated with adult cortisol   concentrations, 
a pattern similar to our own ﬁ  ndings (Vedhara et al., 2007). It 
should be noted that inconsistencies between our own ﬁ  ndings 
and LPS models are not unexpected given fundamental differences 
between live E. coli and puriﬁ  ed LPS; perhaps most importantly, 
E. coli is capable of activating the immune system independent 
of (or in addition to) LPS molecules and toll-like-receptor (TLR) 
4 signaling (e.g., via TLR 2/5/9; (Hayashi et al., 2001; Hemmi et al., 
2000; Steiner et al., 2005), and results in a more prolonged immune 
response.
DEPRESSION
Exaggerated expression of CNS cytokines, including IL-1β, has 
been linked to depression in a large number of studies (Dantzer 
et al., 2008; Hayley et al., 2005; Irwin and Miller, 2007; Maier and 
Watkins, 1998; Pollak and Yirmiya, 2002). Because neonatal E. coli 
infection in rats leads to exaggerated brain cytokine production 
to the LPS challenge in adulthood, we predicted that stressor-
induced depressive-like symptoms would be more severe in these 
rats as well, similar to the memory impairment. To test this idea, 
rats treated on P4 with PBS or E. coli were as adults exposed to 
an acute bout of inescapable tailshock stress, and then tested for 
several well-characterized measures of depressive-like behavior in 
rodents: sucrose preference, social exploration with a juvenile, and 
overall activity following the stressor. Stress increased corticoster-
one and decreased all three behaviors in adult rats compared to 
non-stressed controls, as expected. Surprisingly, however, rats that 
suffered a bacterial infection early in life had blunted corticosterone 
responses during and after the stressor, and recovered much more 
quickly from the depressive symptoms compared to the controls 
(Bilbo et al., 2008b).
Thus, in striking contrast to our data on memory, the same early-
life infection provides a marked protection against stress-induced 
depression in adulthood. This divergence in behavioral outcomes 
is very intriguing, and remains to be more fully explored. Because 
corticosterone leads to cytokine expression in response to stress, 
it is possible that rats infected as neonates exhibited a decrease in 
cytokine production compared to controls, which was ultimately 
protective. A second hypothesis is that an initial   exaggerated 
immune response in the adult may work to resolve inﬂ  ammation 
more quickly. Depressive symptoms are strongly linked to chronic 
inﬂ  ammation (Dantzer et al., 2008). We have evidence, of course, of 
exaggerated brain IL-1β in these animals, which may be indicative 
of changes in overall measures of inﬂ  ammation. If an exaggerated 
initial response results in a faster resolution, then one would predict 
a faster recovery from depression in early-infected rats as well, and 
this is exactly what we observed. From this perspective, memory 
impairment may simply come as a “cost” to this later beneﬁ  t.
CONCLUSIONS
In summary, there is increasing support for a critical role of CNS 
immune cells, primarily microglia, and their products such as 
cytokines, in both health and disease processes within the brain. 
However, the role of immune factors in homeostatic functions such 
as synaptic plasticity, and complex behaviors such as cognition, 
anxiety, and depression remain little understood. We have argued 
here that the early-life environment of an individual is especially 
critical in shaping the way that the immune system and hence the Frontiers in Behavioral Neuroscience  www.frontiersin.org  August 2009  | Volume 3  |  Article 14  |  10
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brain develop, with signiﬁ  cant consequences for brain and behavior 
throughout the remainder of the lifespan.
The available data indicate a number of common inﬂ  uences of 
early-life immune activation on later life brain and behavior, namely 
mechanisms such as cytokine production and glial activation. Thus, 
while we have been working speciﬁ  cally with a model of bacterial 
infection in neonatal rats, we believe the results we have reported 
likely apply more generally to brain-immune interactions. On the 
other hand, the data also suggest a number of challenge (e.g., LPS 
vs. E. coli) and gestational time-point speciﬁ  c inﬂ  uences on later 
outcomes, a further analysis of which will lead to greater understand-
ing of the mechanisms involved. Finally, just as distinct brain regions 
exhibit markedly different functions and cell populations, immune 
activity within each region is likely similarly diverse, and should be 
considered in relation to the microenvironment in which it occurs.
Our data in particular also suggest that the consequences of 
early-life immune challenge should be considered within a cost/
beneﬁ  t perspective, in which outcomes in adulthood may be dif-
ferentially protected or impaired (which may indeed be a conse-
quence of distinct functions depending on different brain regions 
as suggested above). This idea is not without precedence—the 
“hygiene hypothesis” was proposed nearly 20 years ago as a way 
to explain the increased incidence of asthma/allergy and other 
autoimmune disorders in developed countries, and the idea that 
“too-sterile” environments do not provide sufﬁ  cient early training 
for the immune system, with resulting over-reactions in later life 
(Bufford and Gern, 2005; Strachan, 1989). Another elegant exam-
ple of this concept comes from the ﬁ  eld of metabolism in which 
the “fetal origins of adult disease” was ﬁ  rst characterized – Dr. 
Barker and colleagues observed a striking correlation between 
low birth weight (due to famine, and/or fetal growth restric-
tion) and risk for obesity/overweight and its associated health 
problems (e.g., heart disease, diabetes) in adulthood, a causal 
relationship that has since been overwhelmingly conﬁ  rmed in 
animals (Armitage et al., 2008; de Boo and Harding, 2006). This 
hypothesis has been nicknamed the “thrifty phenotype” (Hales 
and Barker, 1992), because in the absence of sufﬁ  cient calories 
in the fetal environment, the neonatal metabolism prepares or 
“programs” the individual to conserve calories, even in adult-
hood. In our modern world of excess food, this becomes maladap-
tive. Similarly, our data provide support for the hypothesis that 
early experience with infectious organisms may help to “tune” 
an appropriate immune responsiveness, and that this has signiﬁ  -
cant consequences, both adaptive and maladaptive, for complex 
behavioral responses throughout life.
In closing, we believe that the data discussed here are small pieces 
of a much larger puzzle, in which the immune system is critically 
involved in normal brain function and, conversely, cognitive/behav-
ioral pathology on a large scale. More research is certainly warranted 
on the extraordinarily complex inﬂ  uence of immune activity on 
neural development, and the role that the brain’s immune response 
plays in adaptive behavior, in both sickness and in health.
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